Chemiluminescent biosensors for pharmaceutical analysis: innovations, challenges, and future prospects.

Journal: Biosensors & bioelectronics
Published Date:

Abstract

Chemiluminescent (CL) biosensors have rapidly emerged as indispensable analytical tools within the multifaceted domains of pharmaceutical research, development, and clinical diagnostics. This prominence stems from their intrinsic attributes such as higher sensitivity, low background noise, and inherent amenability to miniaturization for portable, real-time readout capabilities. This comprehensive review meticulously presents and critically evaluates the most recent innovations in CL-based biosensing platforms specifically engineered for diverse pharmaceutical applications. A primary focus is directed towards the pioneering innovations in the development of CL biosensors with enhanced and tailored emission profiles, the strategic and synergistic integration with an array of sophisticated signal amplification strategies, and the ingenious adaptation of CL detection techniques into highly portable, integrated, and microfluidic devices. Key applications, encompassing stringent drug quality control and authentication, precise pharmacokinetic analysis for personalized medicine, and the critical, rapid detection of counterfeit and substandard medications, are discussed with a rigorous, critical lens, highlighting both their transformative potential and current practical limitations. Furthermore, the review critically assesses emerging prospects, including the advent of advanced wearable sensors for continuous monitoring, the transformative potential of artificial intelligence-assisted diagnostics for data interpretation and predictive modeling, and the imperative for sustainable, eco-friendly reagent design. This article thus serves as both a comprehensive technical resource, elucidating the intricate scientific underpinnings and practical advancements, and a forward-looking perspective on the pivotal and evolving role of chemiluminescent biosensing in modern pharmaceutical analysis.

Authors

  • Muhammad Saqib
    Department of Software Engineering, University of Engineering & Technology, Peshawar, 25000, Pakistan.
  • Yun Lei
    Department of Pharmaceutical Analysis, Higher Educational Key Laboratory for Nano Biomedical Technology of Fujian Province, School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China.
  • Guobao Xu
    State Key Laboratory of Electroanalytical Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin 130022, PR China.
  • Raheel Akram
    Research Laboratory for Analytical Instrument and Electrochemistry Innovation, Department of Chemistry, Faculty of Science, Chiang Mai University, Chiang Mai, 50200, Thailand.
  • Ai-Lin Liu
    Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, People's Republic of China. [email protected].